PITTSBURGH, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the "Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today reported financial results for the fourth quarter ...

Last year, more than $7.5 billion globally went to companies applying advances in artificial intelligence to health-related areas such as medical services and pharmaceutical development, per ...

A lawsuit filed in the Singapore International Commercial Court is seeking $830 million in damages from KBP, with Novo ...

Novo Nordisk is seeking as much as US$830 million in damages in a Singapore court, saying it was misled by a local biotech ...

The Brooklyn Park mayor’s early vision for a vacant swath of land at the city’s northwest corner includes biotech businesses, ...

Dr. Terence Kelly named interim CEO and Prof. Damian O'Connell named Chair of the Scientific Advisory Board, joins Board of Directors- Appointment of US-based CEO completes the ...

Merck’s Keytruda may be the most talked about drug facing loss of exclusivity but it’s far from the only one, as several of ...